Patent · US Active

Hepatitis C virus inhibitors

US9006455B2 · kind B2 · utility

6Cited by
5References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 1, 2013
Grant dateApr 14, 2015
Priority date—
Expiry dateAug 1, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.